Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important ...

The Metastatic Colorectal Cancer Clinical Trials analysis report delivers important insights into ongoing research of 150+ pipeline Metastatic Colorectal Cancer Drugs, clinical strategies, upcoming ...

The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...

A multicenter study shows that a hybrid model combining MRI radiomics, delta features, and clinical variables predicts ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Agenus’ Botvymo and Evamplix receive marketing authorizations from Republic of Armenia for treatment of metastatic colorectal cancer: Lexington, Massachusetts Saturday, October ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Ministry of Health of the Republic of Armenia has granted marketing authorizations for Botvymo® ...

Early-onset colorectal cancer with liver-only metastases can have significant differences in biology from late-onset malignancies.A study of nearly 1,700 individuals from Australia showed early-onset ...

New research reveals that the transcription factor SOX9 drives colorectal cancer metastasis by directly activating the ...

PET-CT is not routinely needed for every colon cancer patient, but it can help in selected cases by identifying suspected ...